This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Wealth Management

Why Goldman Sachs Is Worth the Risk Ahead of Fourth-Quarter Earnings

Why Goldman Sachs Is Worth the Risk Ahead of Fourth-Quarter Earnings

Goldman Sachs is not perfect, but the bank continues to deliver on the bottom line -- where it matters the most.

01/15/15 - 06:08 AM EST

Why BlackRock Is a Strong Buy Ahead of Fourth-Quarter Earnings

BlackRock is the largest asset manager in the world but it could get even bigger.

01/14/15 - 02:40 PM EST

Kerrisdale Launches Campaign to Push Webster Into an HSA Spinoff

Kerrisdale Launches Campaign to Push Webster Into an HSA Spinoff

Activist investor Sahm Adrangi is urging the bank to sell off its health savings account business, arguing that the two units would be worth more separately than they are together.

03/03/15 - 05:38 PM EST

Citigroup Sells Subprime Lender in $4.25 Billion Transaction

Citigroup Sells Subprime Lender in $4.25 Billion Transaction

The sale to Springleaf comes as CEO Michael Corbat faces pressure to hike capital distributions.

03/03/15 - 11:47 AM EST

Hain Celestial Eyes Deals for Personal Care, Cosmetics Businesses

Hain Celestial Eyes Deals for Personal Care, Cosmetics Businesses

  • Tickers in this article:
  • HAIN

The maker of natural and organic food and consumer products wants to double the size of its personal care products portfolio to up to $400 million in sales.

03/03/15 - 10:24 AM EST

Debt-Laden Petrobras Targets $13.7 Billion of Asset Sales

Debt-Laden Petrobras Targets $13.7 Billion of Asset Sales

The Brazilian oil giant needs cash to fund operations and reduce debt amid a corruption probe that risks scaring off lenders.

03/03/15 - 09:11 AM EST

Cardinal Health Acquires Johnson & Johnson's Cordis in a $1.9 Billion Deal

Cardinal Health Acquires Johnson & Johnson's Cordis in a $1.9 Billion Deal

  • Tickers in this article:
  • CAH
  • JNJ

Sale of the cardiac device company is part of Johnson & Johnson's strategy of trimming its portfolio.

03/02/15 - 04:46 PM EST

HP Takes Out Aruba Networks in $2.7 Billion Mobile Technology Play

HP Takes Out Aruba Networks in $2.7 Billion Mobile Technology Play

The bid of $24.67 per share marks a discount to Friday's close, sending the target's shares lower in early trading.

03/02/15 - 01:00 PM EST

Boston Scientific Buys Endo's Urology Device Business in $1.6 Billion Deal

Boston Scientific Buys Endo's Urology Device Business in $1.6 Billion Deal

  • Tickers in this article:
  • BSX
  • ENDP

Sale of its men’s urology portfolio continues Endo’s move into pharmaceuticals.

03/02/15 - 11:57 AM EST

NXP Semiconductors Drives Off With Freescale in $16.7 Billion Deal

NXP Semiconductors Drives Off With Freescale in $16.7 Billion Deal

  • Tickers in this article:
  • NXPI
  • FSL

The Dutch suitor is hoping the hype around self-driving cars will mean a boon to its business.

03/02/15 - 09:42 AM EST

NXP Semiconductors Near Deal to Buy Freescale for $40 Billion

NXP Semiconductors Near Deal to Buy Freescale for $40 Billion

  • Tickers in this article:
  • FSL
  • AAPL

NXP Semiconductors is close to a deal to acquire rival Freescale Semiconductor FSL in a $40 billion cash and stock merger, according to news reports.

03/01/15 - 08:27 PM EST

AC/DG: The Powerful Appeal of Getting Off the Grid, Going Renewable

AC/DG: The Powerful Appeal of Getting Off the Grid, Going Renewable

Distributed generation is becoming more feasible, raising the specter of a “death spiral” for utilities.

02/27/15 - 04:12 PM EST

A Battle Rages Over Whether an Old Drug Can Be New Again

A Battle Rages Over Whether an Old Drug Can Be New Again

  • Tickers in this article:
  • UTHR
  • NVS

Takeover candidate United Therapeutics fights Sandoz over patents for treating a rare disorder.

02/27/15 - 01:58 PM EST

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

02/27/15 - 12:51 PM EST

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs